Cargando…
Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427725/ https://www.ncbi.nlm.nih.gov/pubmed/32795288 http://dx.doi.org/10.1186/s12936-020-03274-w |
_version_ | 1783570935917314048 |
---|---|
author | Pathak, Ashish Mårtensson, Andreas Gawariker, Sudhir Sharma, Ashish Diwan, Vishal Purohit, Manju Ursing, Johan |
author_facet | Pathak, Ashish Mårtensson, Andreas Gawariker, Sudhir Sharma, Ashish Diwan, Vishal Purohit, Manju Ursing, Johan |
author_sort | Pathak, Ashish |
collection | PubMed |
description | BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. METHODS: Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. RESULTS: Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. CONCLUSION: The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use. |
format | Online Article Text |
id | pubmed-7427725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74277252020-08-17 Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India Pathak, Ashish Mårtensson, Andreas Gawariker, Sudhir Sharma, Ashish Diwan, Vishal Purohit, Manju Ursing, Johan Malar J Research BACKGROUND: Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. METHODS: Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. RESULTS: Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. CONCLUSION: The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use. BioMed Central 2020-08-14 /pmc/articles/PMC7427725/ /pubmed/32795288 http://dx.doi.org/10.1186/s12936-020-03274-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pathak, Ashish Mårtensson, Andreas Gawariker, Sudhir Sharma, Ashish Diwan, Vishal Purohit, Manju Ursing, Johan Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title | Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title_full | Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title_fullStr | Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title_full_unstemmed | Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title_short | Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India |
title_sort | stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of k13 mutations in plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in ujjain, madhya pradesh, india |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427725/ https://www.ncbi.nlm.nih.gov/pubmed/32795288 http://dx.doi.org/10.1186/s12936-020-03274-w |
work_keys_str_mv | AT pathakashish stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT martenssonandreas stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT gawarikersudhir stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT sharmaashish stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT diwanvishal stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT purohitmanju stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia AT ursingjohan stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia |